Many bacteriophages can modulate host transcription. Here, the authors uncover the anti-termination mechanism of phage satellite P4 protein, Psu. Psu dimers clamp two open rings of the termination ...
The US government has provided almost $24 million in funding to Locus Biosciences to support a mid-stage trial of LBP-EC01, a CRISPR-engineered bacteriophage therapy in development for resistant ...
Jan. 2, 2025 — A new study uncovers how a novel immunotherapy prevents squamous cell carcinoma, with benefits lasting five years after treatment. This therapy is the first to activate specific ...
APT's platform is based on a growing library of bacteriophages, viruses that infect and kill bacteria, that could be used to treat a range of multi-drug resistant (MDR) pathogens, and the Fund's $ ...